<DOC>
	<DOCNO>NCT01588366</DOCNO>
	<brief_summary>This study involve multiple dos study drug ( 60 mg LY2409021 , 15 mg LY2409021 placebo ) take capsule mouth daily basis 28 day . This study image liver use magnetic resonance imaging ( MRI ) magnetic resonance spectroscopy ( MRS ) healthy participant participant type 2 diabetes mellitus , take LY2409021 see liver change happen time change blood test . This study approximately 11 week long , include screening . A screening appointment require within 28 day prior start study .</brief_summary>
	<brief_title>The Effects LY2409021 Liver</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>For participant : Must male , female become pregnant , either healthy participant , type 2 diabetes Must body mass index ( BMI ) 18.5 29.9 kilogram per square meter ( kg/m^2 ) healthy participant , BMI 18.5 35.0 kg/m^2 diabetic For participant type 2 diabetes mellitus ( T2DM ) : On diet exercise treatment , take metformin For participant : Have sign symptom liver disease Are infect hepatitis B hepatitis C Have donate 450 mL blood last 3 month donate blood last month Smoke 10 cigarette per day willing abstain smoking clinic Have surgery metallic clip , staple stent , cardiac pacemaker ( surgical implant ) insert part body , fear enclose space symptoms prevent send magnetic resonance imaging ( MRI ) scan For participant T2DM : Are use insulin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>